Business

Moderna’s Cancer Vaccine Success

Updated 2026-08-19 12:25 UTC 1 source Positive

Moderna's stock surged as much as 100% after promising results from a clinical trial of its cancer vaccine candidate. The vaccine pairs mRNA therapy with the immunotherapy drug Keytruda.

Coverage timeline — 1 article

MarketWatch

Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

2026-08-19 12:15 UTC